This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 19 - 25 November 2023 and includes updates on updates SARS-CoV-2 variant classifications, the increase of pediatric respiratory infections in China, Avian influenza in fur farms, West Nile virus, cholera, and an overview of respiratory virus epidemiology.
Genetic and antigenic characterization data generated at the Worldwide Influenza Centre for viruses with collection dates after 31 January 2023 until 31 August 2023 informed the WHO influenza vaccine composition meeting (VCM) in September 2023 when recommendations were made for the southern hemisphere (SH) 2024 influenza season.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 12 - 18 November 2023 and includes updates on SARS-CoV-2 variant classification, West Nile virus, multistate outbreak of salmonella, and an overview of respiratory virus epidemiology in the EU/EEA.
In 2023 and until the beginning of November, over 4.5 million cases and over 4 000 dengue-related deaths have been reported from 80 countries/territories globally.
In 2023 and until the beginning of November, over 4.5 million cases and over 4 000 dengue-related deaths have been reported from 80 countries/territories globally.
Since April 2012, and as of 6 November 2023, a total of 2 617 cases of MERS-CoV, including 947 deaths, have been reported by health authorities worldwide.
Since April 2012, and as of 6 November 2023, a total of 2 617 cases of MERS-CoV, including 947 deaths, have been reported by health authorities worldwide.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 5 - 11 November 2023 and includes updates on SARS-CoV-2 variants, an overview of respiratory virus epidemiology in the EU/EEA, West Nile Virus, measles, diphtheria, Middle East respiratory virus syndrome, chikungunya, and dengue.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 22-28 October 2023 and includes updates on poliomyelitis, SARS-CoV-2, West Nile virus, the Rugby World Cup 2023, and cryptosporidiosis cases.